Altered Generation of Induced Regulatory T Cells in the FVB.mdr1a-/- Mouse Model of Colitis

Overview

Journal Mucosal Immunol

Publisher Elsevier

Specialty Allergy & Immunology

Date 2012 Aug 10

PMID 22874899

Citations 17

Authors

S M Tanner

E M Staley

R G Lorenz

Affiliations

Soon will be listed here.

Abstract

The FVB.mdr1a(-/-) mouse, lacking the small molecule pump P-glycoprotein (P-gp), is a commonly used model for the study of spontaneous T cell-mediated colitis. In addition, MDR1 polymorphisms and P-gp deficiency in humans have been linked to the development of ulcerative colitis. We now demonstrate that mice with P-gp deficiency have decreased levels of Foxp3(+) regulatory T cells (Tregs) in the intestinal lamina propria. This decrease is not due to either increased Treg apoptosis, altered Treg trafficking, or enhanced Treg plasticity to become Foxp3(+)IL-17(+) cells. Instead, P-gp deficiency appears to restrict the development of induced Treg cells (iTregs), as fewer Foxp3(+) iTregs developed from naive FVB.mdr1a(-/-) T cells both upon transforming growth factor-β (TGF-β) treatment in vitro and after adoptive transfer into FVB.rag2(-/-) recipients. Rather, in vitro TGF-β treatment results in a IL-17(+)CD4(+) T cell. This failure of iTregs to develop explains the decrease in Foxp3(+) Tregs in the FVB.mdr1a(-/-) intestine, representing a need to investigate this novel disease mechanism in human inflammatory bowel disease patients with MDR1 polymorphisms.

Citing Articles

P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease.

Ahmed Juvale I, Abdul Hamid A, Abd Halim K, Che Has A Heliyon. 2022; 8(6):e09777.

PMID: 35789865 PMC: 9249865. DOI: 10.1016/j.heliyon.2022.e09777.

ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance.

Muriithi W, Wanjiku Macharia L, Pilotto Heming C, Echevarria J, Nyachieo A, Niemeyer Filho P Cancer Biol Med. 2020; 17(2):253-269.

PMID: 32587767 PMC: 7309456. DOI: 10.20892/j.issn.2095-3941.2019.0284.

Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes.

Chen M, Sun A, Cao W, Eliason A, Mendez K, Getzler A J Exp Med. 2020; 217(5).

PMID: 32302378 PMC: 7201929. DOI: 10.1084/jem.20191388.

Steroids, Pregnancy and Fetal Development.

Solano M, Arck P Front Immunol. 2020; 10:3017.

PMID: 32038609 PMC: 6987319. DOI: 10.3389/fimmu.2019.03017.

MDR1 in immunity: friend or foe?.

Bossennec M, Di Roio A, Caux C, Menetrier-Caux C Oncoimmunology. 2018; 7(12):e1499388.

PMID: 30524890 PMC: 6279327. DOI: 10.1080/2162402X.2018.1499388.

References

Cong Y, Weaver C, Lazenby A, Elson C . Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol. 2002; 169(11):6112-9. DOI: 10.4049/jimmunol.169.11.6112. View

Schinkel A, Smit J, van Tellingen O, Beijnen J, Wagenaar E, van Deemter L . Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994; 77(4):491-502. DOI: 10.1016/0092-8674(94)90212-7. View

Fujiwara D, Chen L, Wei B, Braun J . Small intestine CD11c+ CD8+ T cells suppress CD4+ T cell-induced immune colitis. Am J Physiol Gastrointest Liver Physiol. 2011; 300(6):G939-47. PMC: 3119121. DOI: 10.1152/ajpgi.00032.2010. View

Saruta M, Yu Q, Fleshner P, Mantel P, Schmidt-Weber C, Banham A . Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin Immunol. 2007; 125(3):281-90. DOI: 10.1016/j.clim.2007.08.003. View

Sun C, Hall J, Blank R, Bouladoux N, Oukka M, Rodrigo Mora J . Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med. 2007; 204(8):1775-85. PMC: 2118682. DOI: 10.1084/jem.20070602. View

Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, HUBER H . Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood. 1992; 80(11):2729-34. View

Randolph G, Beaulieu S, Pope M, Sugawara I, Hoffman L, Steinman R . A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci U S A. 1998; 95(12):6924-9. PMC: 22688. DOI: 10.1073/pnas.95.12.6924. View

Onnie C, Fisher S, Pattni R, Sanderson J, Forbes A, Lewis C . Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm Bowel Dis. 2006; 12(4):263-71. DOI: 10.1097/01.MIB.0000209791.98866.ba. View

Schmitz J, Durham C, Ho S, Lorenz R . Gastric mucus alterations associated with murine Helicobacter infection. J Histochem Cytochem. 2009; 57(5):457-67. PMC: 2675072. DOI: 10.1369/jhc.2009.952473. View

10.

van de Ven R, Scheffer G, Scheper R, de Gruijl T . The ABC of dendritic cell development and function. Trends Immunol. 2009; 30(9):421-9. DOI: 10.1016/j.it.2009.06.004. View

11.

Boschetti G, Nancey S, Sardi F, Roblin X, Flourie B, Kaiserlian D . Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Inflamm Bowel Dis. 2010; 17(1):160-70. DOI: 10.1002/ibd.21308. View

12.

Fantini M, Becker C, Monteleone G, Pallone F, Galle P, Neurath M . Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004; 172(9):5149-53. DOI: 10.4049/jimmunol.172.9.5149. View

13.

Zhou X, Bailey-Bucktrout S, Jeker L, Penaranda C, Martinez-Llordella M, Ashby M . Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009; 10(9):1000-7. PMC: 2729804. DOI: 10.1038/ni.1774. View

14.

Murai M, Krause P, Cheroutre H, Kronenberg M . Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol. 2010; 3(5):443-9. PMC: 2924438. DOI: 10.1038/mi.2010.27. View

15.

Feng T, Cao A, Weaver C, Elson C, Cong Y . Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis. Gastroenterology. 2011; 140(7):2031-43. PMC: 3109200. DOI: 10.1053/j.gastro.2011.03.009. View

16.

Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299(5609):1057-61. DOI: 10.1126/science.1079490. View

17.

Sukhai M, Yong A, Pak A, Piquette-Miller M . Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes. Inflamm Res. 2001; 50(7):362-70. DOI: 10.1007/PL00000257. View

18.

Kleinewietfeld M, Puentes F, Borsellino G, Battistini L, Rotzschke O, Falk K . CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood. 2004; 105(7):2877-86. DOI: 10.1182/blood-2004-07-2505. View

19.

Ho G, Soranzo N, Nimmo E, Tenesa A, Goldstein D, Satsangi J . ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet. 2006; 15(5):797-805. DOI: 10.1093/hmg/ddi494. View

20.

Rao P, Petrone A, Ponath P . Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}. J Immunol. 2005; 174(3):1446-55. DOI: 10.4049/jimmunol.174.3.1446. View